FDA Approved: DIFLUPREDNATE OPHTHALMIC — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for difluprednate ophthalmic submitted by Sandoz Inc, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation
• Postoperative Ocular Inflammation and Pain

Drugs mentioned

• Difluprednate ophthalmic emulsion (difluprednate)

Snippet

SUPPL AP for DIFLUPREDNATE OPHTHALMIC (DIFLUPREDNATE OPHTHALMIC)